{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:50:12Z","timestamp":1794376212414,"version":"4.9.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507500"],"award-info":[{"award-number":["2023YFC2507500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200678"],"award-info":[{"award-number":["82200678"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430022"],"award-info":[{"award-number":["82430022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900543"],"award-info":[{"award-number":["81900543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030021"],"award-info":[{"award-number":["82030021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jhep.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:51:32Z","timestamp":1778547092000},"page":"515-527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid"],"prefix":"10.1016","volume":"85","author":[{"given":"Hai-Lin","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7368-9414","authenticated-orcid":false,"given":"Qi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-5457","authenticated-orcid":false,"given":"Li-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Tong","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia-Lu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Peng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-112X","authenticated-orcid":false,"given":"Wei-Fen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2026.05.001_bib1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.05.001_bib2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2026.05.001_bib3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2023.04.028","article-title":"TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis","volume":"79","author":"Larrue","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.05.001_bib4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhep.2022.05.021","article-title":"Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis","volume":"77","author":"Villanueva","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.05.001_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cgh.2019.05.050","article-title":"Lowering portal pressure improves outcomes of patients with cirrhosis, with or without ascites: a meta-analysis","volume":"18","author":"Turco","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.05.001_bib6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2468-1253(23)00438-7","article-title":"Pathophysiology and therapeutic options for cirrhotic portal hypertension","volume":"9","author":"Guix\u00e9-Muntet","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.05.001_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12072-021-10135-4","article-title":"Regression of portal hypertension: underlying mechanisms and therapeutic strategies","volume":"15","author":"Selicean","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2026.05.001_bib8","article-title":"Mechanobiology of portal hypertension","volume":"5","author":"Felli","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.05.001_bib9","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/liv.15559","article-title":"Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension","volume":"43","author":"Turco","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.05.001_bib10","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","article-title":"AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis","volume":"79","author":"Kaplan","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.05.001_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107626","article-title":"Novel therapeutics for portal hypertension and fibrosis in chronic liver disease","volume":"215","author":"Guix\u00e9-Muntet","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jhep.2026.05.001_bib12","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/ajg.2017.175","article-title":"Trends in 30-day and 1-year mortality among patients hospitalized with cirrhosis from 2004 to 2013","volume":"112","author":"Kanwal","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2026.05.001_bib13","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/hep.1840200405","article-title":"Blood and plasma 5-hydroxytryptamine levels in patients with cirrhosis","volume":"20","author":"Beaudry","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.05.001_bib14","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.3748\/wjg.v13.i43.5750","article-title":"Plasma and platelet serotonin levels in patients with liver cirrhosis","volume":"13","author":"Culafic","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2026.05.001_bib15","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.3748\/wjg.v16.i48.6135","article-title":"Role of serotonin in development of esophageal and gastric fundal varices","volume":"16","author":"Rudi\u0107","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2026.05.001_bib16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/j.gastro.2024.06.007","article-title":"Targeting 5-hydroxytryptamine receptor 1A in the portal vein to decrease portal hypertension","volume":"167","author":"Zhu","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.05.001_bib17","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/hep.29646","article-title":"Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis","volume":"67","author":"Garc\u00eda-Lezana","year":"2018","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2026.05.001_bib18","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jhep.2020.11.013","article-title":"The microbiota in cirrhosis and its role in hepatic decompensation","volume":"75","author":"Trebicka","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.05.001_bib19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2026.05.001_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.chom.2022.11.006","article-title":"Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis","volume":"31","author":"Zhai","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2026.05.001_bib21","article-title":"The mechanism of secretion and metabolism of gut-derived 5-hydroxytryptamine","volume":"22","author":"Liu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2026.05.001_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117283","article-title":"Therapeutic potential of rifaximin in liver diseases","volume":"178","author":"Yang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jhep.2026.05.001_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.841132","article-title":"Rifaximin ameliorates non-alcoholic steatohepatitis in mice through regulating gut microbiome-related bile acids","volume":"13","author":"Jian","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhep.2026.05.001_bib24","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/jgh.16484","article-title":"Rifaximin treatment shapes a unique metagenome-metabolism network in patients with decompensated cirrhosis","volume":"39","author":"Nie","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.05.001_bib25","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-2036.2009.03958.x","article-title":"Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis","volume":"29","author":"Vlachogiannakos","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2026.05.001_bib26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jhep.2011.11.013","article-title":"Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice","volume":"56","author":"Zhu","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.05.001_bib27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.5009\/gnl16478","article-title":"Rifaximin and propranolol combination therapy is more effective than propranolol monotherapy for the reduction of portal pressure: an open randomized controlled pilot study","volume":"11","author":"Lim","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.jhep.2026.05.001_bib28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.28898","article-title":"Rifaximin has no effect on hemodynamics in decompensated cirrhosis: a randomized, double-blind, placebo-controlled trial","volume":"65","author":"Kimer","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.05.001_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tips.2020.12.002","article-title":"Advances in targeting GIRK channels in disease","volume":"42","author":"Zhao","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jhep.2026.05.001_bib30","doi-asserted-by":"crossref","first-page":"18793","DOI":"10.18632\/aging.104026","article-title":"GIRK channels in Alzheimer's disease","volume":"12","author":"Lieberman","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jhep.2026.05.001_bib31","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1113\/jphysiol.2014.279083","article-title":"5-Hydroxytryptamine1A receptor-activation hyperpolarizes pyramidal cells and suppresses hippocampal gamma oscillations via Kir3 channel activation","volume":"592","author":"Johnston","year":"2014","journal-title":"J Physiol"},{"key":"10.1016\/j.jhep.2026.05.001_bib32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.05.001_bib33","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00535-024-02134-7","article-title":"Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation","volume":"59","author":"Hao","year":"2024","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2026.05.001_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3350\/cmh.2012.18.4.337","article-title":"The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension","volume":"18","author":"Seo","year":"2012","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhep.2026.05.001_bib35","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2026.05.001_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","article-title":"Gut microbial metabolites as multi-kingdom intermediates","volume":"19","author":"Krautkramer","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jhep.2026.05.001_bib37","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.05.001_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","article-title":"Bile acid metabolism and signalling in liver disease","volume":"82","author":"Fuchs","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.05.001_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2012.09.055","article-title":"The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice","volume":"144","author":"Alemi","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.05.001_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087467","article-title":"5HT1AR-FGFR1 heteroreceptor complexes differently modulate GIRK currents in the dorsal Hippocampus and the dorsal raphe serotonin nucleus of control rats and of a genetic rat model of depression","volume":"24","author":"Ambrogini","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2026.05.001_bib41","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.cellsig.2010.03.019","article-title":"5-HT1A receptor-regulated signal transduction pathways in brain","volume":"22","author":"Polter","year":"2010","journal-title":"Cell Signal"},{"key":"10.1016\/j.jhep.2026.05.001_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107808","article-title":"Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system","volume":"223","author":"Jeremic","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jhep.2026.05.001_bib43","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.12659\/MSM.900152","article-title":"Phosphorylated myosin light chain 2 (p-MLC2) as a molecular marker of antemortem coronary artery spasm","volume":"22","author":"Li","year":"2016","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jhep.2026.05.001_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/cvr\/cvy023","article-title":"Vascular smooth muscle contraction in hypertension","volume":"114","author":"Touyz","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jhep.2026.05.001_bib45","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/CIRCULATIONAHA.121.058607","article-title":"Novel smooth muscle Ca(2+)-signaling nanodomains in blood pressure regulation","volume":"146","author":"Chen","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2026.05.001_bib46","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/hep.31708","article-title":"The use of rifaximin in patients with cirrhosis","volume":"74","author":"Caraceni","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.05.001_bib47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12072-017-9798-x","article-title":"Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg","volume":"12","author":"Arab","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2026.05.001_bib48","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/liv.13986","article-title":"Potential mechanisms linking gut microbiota and portal hypertension","volume":"39","author":"Baffy","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.05.001_bib49","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1949095","article-title":"Effect of different bile acids on the intestine through enterohepatic circulation based on FXR","volume":"13","author":"Xiang","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jhep.2026.05.001_bib50","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10753-021-01573-1","article-title":"Deoxycholic acid promotes pyroptosis in free fatty acid-induced steatotic hepatocytes by inhibiting PINK1-mediated mitophagy","volume":"45","author":"Gao","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.jhep.2026.05.001_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2026.05.001_bib52","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","article-title":"Pathophysiology of decompensated cirrhosis: portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction","volume":"75","author":"Engelmann","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.05.001_bib53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1476-5381.1986.tb11150.x","article-title":"Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats","volume":"89","author":"Cummings","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jhep.2026.05.001_bib54","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1073\/pnas.94.3.923","article-title":"Normal cerebellar development but susceptibility to seizures in mice lacking G protein-coupled, inwardly rectifying K+ channel GIRK2","volume":"94","author":"Signorini","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2026.05.001_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziae108","article-title":"Girk3 deletion increases osteoblast maturation and bone mass accrual in adult male mice","volume":"8","author":"Weaver","year":"2024","journal-title":"JBMR Plus"},{"key":"10.1016\/j.jhep.2026.05.001_bib56","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ajhg.2010.04.017","article-title":"Identification of a Kir3.4 mutation in congenital long QT syndrome","volume":"86","author":"Yang","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jhep.2026.05.001_bib57","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2026.05.001_bib58","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12072-020-10117-y","article-title":"Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis","volume":"15","author":"Zeng","year":"2021","journal-title":"Hepatol Int"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826002709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826002709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T06:38:44Z","timestamp":1787380724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827826002709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0168827826002709"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.05.001","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}